Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharma (FARN)

Price 155.00p on 08-05-2024 at 16:30:04
Change 0.00p 0%
Buy 160.00p
Sell 150.00p
Buy / Sell FARN Shares
Last Trade: Sell 350.00 at 153.50p
Day's Volume: 4,379
Last Close: 155.00p
Open: 155.00p
ISIN: FI4000153309
Day's Range 155.00p - 155.00p
52wk Range: 113.00p - 360.00p
Market Capitalisation: £112m
VWAP: 157.93265p
Shares in Issue: 72m

Listed In: FTSE AIM All-Share,

Recent Trades History Faron Pharma (FARN)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 350 153.50p Ordinary
13:27:37 - 08-May-24
Sell* 62 150.00p Ordinary
10:47:16 - 08-May-24
Buy* 62 160.00p Ordinary
08:44:36 - 08-May-24
Buy* 1,879 159.00p Ordinary
08:23:56 - 08-May-24
Buy* 2,026 157.888p Ordinary
07:07:31 - 08-May-24

Share Price History for Faron Pharma

Time period:
to
Date Open High Low Close Volume

Share News for Faron Pharma

TRADING UPDATES: Kelso raises stake in NCC; Transense joins project

3rd May 2024 13:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News: Read More

Faron Pharmaceuticals reappoints former finance chief on interim basis

15th Apr 2024 10:58

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it appointed a new interim chief financial officer to replace the outgoing James O'Brien. Read More

UPDATE: Faron Pharmaceuticals promotes COO to CEO as father retires

8th Apr 2024 11:50

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace his father, the company's founder. Read More

Faron Pharmaceuticals promotes COO to CEO as founder steps back

8th Apr 2024 11:28

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace the company's founder. Read More

Faron Pharmaceuticals secures funding to deliver next "milestones"

4th Apr 2024 11:58

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it has successfully raised funds to support the phase two study of its bexmarilimab cancer treatment. Read More

FTSE 100 Latest
Value8,354.05
Change40.38

Login to your account

Forgot Password?

Not Registered